UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048167
Receipt number R000054864
Scientific Title A Prospective Observational Study Evaluating the Efficacy of an Induction Protocol of Ventricular Premature Complexes Originated from Outflow Tract in Catheter Ablation
Date of disclosure of the study information 2022/06/25
Last modified on 2022/06/25 17:11:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Prospective Observational Study Evaluating the Efficacy of an Induction Protocol of Ventricular Premature Complexes Originated from Outflow Tract in Catheter Ablation

Acronym

A Prospective Observational Study Evaluating the Efficacy of an Induction Protocol of Ventricular Premature Complexes Originated from Outflow Tract in Catheter Ablation

Scientific Title

A Prospective Observational Study Evaluating the Efficacy of an Induction Protocol of Ventricular Premature Complexes Originated from Outflow Tract in Catheter Ablation

Scientific Title:Acronym

A Prospective Observational Study Evaluating the Efficacy of an Induction Protocol of Ventricular Premature Complexes Originated from Outflow Tract in Catheter Ablation

Region

Japan


Condition

Condition

Ventricular arrhythmia

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the predictor of a procedural success in cahter ablation therapy for ventricular premature complexes originated from outflow tract

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

A predictor of a procedural success in cahter ablation therapy for ventricular premature complexes originated from outflow tract

Key secondary outcomes

1. A burden of premature ventricular complexes by each indcution protocol
2. A burden of premature ventricular complexes accoring to the origin of premature ventricular complexes
3. A predictor of the recurrence of premature ventricular complexes during follow up period
4. Relationship between the induction protocol and the burden or time with ventricular complexes
5. Adverse event by the induction protocols


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Age older than 20 years
2.The patient is willing and able to comply with the protocol and has provided written informed consent

Key exclusion criteria

The patient who the investigators admit is not not appropriate to include in the study

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Masaya
Middle name
Last name Watanabe

Organization

Hokkaido University Hospital

Division name

Department of cardiovascular medicine

Zip code

060-8638

Address

North 15, West 7, Kita-ku, Sapporo city

TEL

0117066973

Email

m.watanabe@huhp.hokudai.ac.jp


Public contact

Name of contact person

1st name Masaya
Middle name
Last name Watanabe

Organization

Hokkaido University

Division name

Department of cardiovascular medicine

Zip code

060-8638

Address

North 15, West 7, Kita-ku, Sapporo city

TEL

0117066973

Homepage URL


Email

m.watanabe@huhp.hokudai.ac.jp


Sponsor or person

Institute

Department of Cardiovascular Medicine
Hokkaido University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Department of Cardiovascular Medicine
Hokkaido University Graduate School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hokkaido University Hospital

Address

North 15, West 7, Kita-ku, Sapporo city

Tel

0117066973

Email

m.watanabe@huhp.hokudai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 06 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2021 Year 11 Month 02 Day

Date of IRB

2021 Year 11 Month 02 Day

Anticipated trial start date

2021 Year 11 Month 26 Day

Last follow-up date

2033 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

none


Management information

Registered date

2022 Year 06 Month 25 Day

Last modified on

2022 Year 06 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054864